-
1
-
-
78650768828
-
-
Unites States Renal Data System. annual data report
-
Unites States Renal Data System. 2009 annual data report. Chapter 12. International Comparison, Available at http://www.usrds.org/2009/pdf/V2_12_09.PDF:343-54 [accessed on 5 Sep 2010].
-
(2009)
-
-
-
2
-
-
4243383993
-
The long-term outcome of glomerular disease
-
Schrier RW, Gottschalk CW, eds. Boston, MA: Little, Brown
-
Cameron JS. The long-term outcome of glomerular disease, In: Schrier RW, Gottschalk CW, eds. Disease of the Kidney. Boston, MA: Little, Brown 1988; 2127-89.
-
(1988)
Disease of the Kidney
, pp. 2127-2189
-
-
Cameron, J.S.1
-
3
-
-
0023072028
-
Variations of primary glomerulonephritis incidence in a rural area of 400,000 inhabitants in the last decade
-
Simon P, Ramée MP, Ang KS, Cam G. Variations of primary glomerulonephritis incidence in a rural area of 400,000 inhabitants in the last decade. Nephron 1987; 45: 171.
-
(1987)
Nephron
, vol.45
, pp. 171
-
-
Simon, P.1
Ramée, M.P.2
Ang, K.S.3
Cam, G.4
-
4
-
-
0034947279
-
The incidence of biopsy-proven glomerulonephritis in Australia
-
Briganti EM, Dowling J, Finlay M, Hill PA, Jones CL, Kincaid-Smith PS, Sinclair R, McNeil JJ, Atkins RC. The incidence of biopsy-proven glomerulonephritis in Australia. Nephrol Dial Transplant 2001; 16: 1364-7.
-
(2001)
Nephrol Dial Transplant
, vol.16
, pp. 1364-1367
-
-
Briganti, E.M.1
Dowling, J.2
Finlay, M.3
Hill, P.A.4
Jones, C.L.5
Kincaid-Smith, P.S.6
Sinclair, R.7
McNeil, J.J.8
Atkins, R.C.9
-
5
-
-
0032794344
-
The epidemiology and prognosis of glomerulonephritis in Denmark 1985-1997
-
Heaf J, Løkkegaard H, Larsen S. The epidemiology and prognosis of glomerulonephritis in Denmark 1985-1997. Nephrol Dial Transplant 1999; 14: 1889-97.
-
(1999)
Nephrol Dial Transplant
, vol.14
, pp. 1889-1897
-
-
Heaf, J.1
Løkkegaard, H.2
Larsen, S.3
-
6
-
-
4344621055
-
Outcome study of renal biopsy patients in Okinawa
-
Iseki K, Miyasato F, Uehara H, Tokuyama K, Toma S, Nishime K, Yoshi S, Shiohira Y, Oura T, Tozawa M, Fukiyama K. Outcome study of renal biopsy patients in Okinawa, Japan. Kidney Int 2004; 66: 914-9.
-
(2004)
Japan. Kidney Int
, vol.66
, pp. 914-919
-
-
Iseki, K.1
Miyasato, F.2
Uehara, H.3
Tokuyama, K.4
Toma, S.5
Nishime, K.6
Yoshi, S.7
Shiohira, Y.8
Oura, T.9
Tozawa, M.10
Fukiyama, K.11
-
7
-
-
0013873623
-
The association of cancer and the nephrotic syndrome
-
Lee JC, Yamauchi H, Hopper J Jr. The association of cancer and the nephrotic syndrome. Ann Intern Med 1966; 64: 41-51.
-
(1966)
Ann Intern Med
, vol.64
, pp. 41-51
-
-
Lee, J.C.1
Yamauchi, H.2
Hopper J., Jr.3
-
8
-
-
33749531233
-
GN-PROGRESS Study Group. Membranous nephropathy and cancer: Epidemiologic evidence and determinants of high-risk cancer association
-
Lefaucheur C, Stengel B, Nochy D, Martel P, Hill GS, Jacquot C, Rossert J. GN-PROGRESS Study Group. Membranous nephropathy and cancer: Epidemiologic evidence and determinants of high-risk cancer association. Kidney Int 2006; 70: 1510-7.
-
(2006)
Kidney Int
, vol.70
, pp. 1510-1517
-
-
Lefaucheur, C.1
Stengel, B.2
Nochy, D.3
Martel, P.4
Hill, G.S.5
Jacquot, C.6
Rossert, J.7
-
9
-
-
0037249050
-
Glomerulonephritis and malignancy: a population-based analysis
-
Birkeland SA, Storm HH. Glomerulonephritis and malignancy: a population-based analysis. Kidney Int 2003; 63: 716-21.
-
(2003)
Kidney Int
, vol.63
, pp. 716-721
-
-
Birkeland, S.A.1
Storm, H.H.2
-
11
-
-
0014975026
-
Acute nephrotic syndrome as a manifestation of active Hodgkin's Disease. Report of four cases and review of the literature
-
Plager J, Stutzman L. Acute nephrotic syndrome as a manifestation of active Hodgkin's Disease. Report of four cases and review of the literature. Am J Med 1971; 50: 56-66.
-
(1971)
Am J Med
, vol.50
, pp. 56-66
-
-
Plager, J.1
Stutzman, L.2
-
12
-
-
28844504752
-
Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis
-
Casas JP, Chua W, Loukogeorgakis S, Vallance P, Smeeth L, Hingorani AD, MacAllister RJ. Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis. Lancet 2005; 366: 2026-33.
-
(2005)
Lancet
, vol.366
, pp. 2026-2033
-
-
Casas, J.P.1
Chua, W.2
Loukogeorgakis, S.3
Vallance, P.4
Smeeth, L.5
Hingorani, A.D.6
MacAllister, R.J.7
-
13
-
-
62449126418
-
Progressive REnal disease and Medical Informatics and gEnomics Research (PREMIER) members. The mildly elevated serum bilirubin level is negatively associated with the incidence of end stage renal disease in patients with IgA nephropathy
-
Chin HJ, Cho HJ, Lee TW, Na KY, Oh KH, Joo KW, Yoon HJ, Kim YS, Ahn C, Han JS, Kim S, Jeon ES, Jin DC, Kim YL, Park SH, Kim CD, Song YR, Kim SG, Kim YG, Lee JE, Oh YK, Lim CS, Lee SK, Chae DW, Cho WY, Kim HK, Jo SK, Progressive REnal disease and Medical Informatics and gEnomics Research (PREMIER) members. The mildly elevated serum bilirubin level is negatively associated with the incidence of end stage renal disease in patients with IgA nephropathy. J Korean Med Sci 2009; 24 Suppl 1: S22-9.
-
(2009)
J Korean Med Sci
, vol.24
, Issue.SUPPL 1
-
-
Chin, H.J.1
Cho, H.J.2
Lee, T.W.3
Na, K.Y.4
Oh, K.H.5
Joo, K.W.6
Yoon, H.J.7
Kim, Y.S.8
Ahn, C.9
Han, J.S.10
Kim, S.11
Jeon, E.S.12
Jin, D.C.13
Kim, Y.L.14
Park, S.H.15
Kim, C.D.16
Song, Y.R.17
Kim, S.G.18
Kim, Y.G.19
Lee, J.E.20
Oh, Y.K.21
Lim, C.S.22
Lee, S.K.23
Chae, D.W.24
Cho, W.Y.25
Kim, H.K.26
Jo, S.K.27
more..
-
14
-
-
77954030665
-
Angiotensinreceptor blockade and risk of cancer: meta-analysis of randomised controlled trials
-
Sipahi I, Debanne SM, Rowland DY, Simon DI, Fang JC. Angiotensinreceptor blockade and risk of cancer: meta-analysis of randomised controlled trials. Lancet Oncol 2010; 11: 627-36.
-
(2010)
Lancet Oncol
, vol.11
, pp. 627-636
-
-
Sipahi, I.1
Debanne, S.M.2
Rowland, D.Y.3
Simon, D.I.4
Fang, J.C.5
-
15
-
-
62449084818
-
Progressive REnal disease and Medical Informatics and gEnomics Research (PREMIER) members. The hemeoxygenase-1 genotype is a risk factor to renal impairment of IgA nephropathy at diagnosis, which is a strong predictor of mortality
-
Chin HJ, Cho HJ, Lee TW, Na KY, Yoon HJ, Chae DW, Kim S, Jeon US, Do JY, Park JW, Yoon KW, Shin YT, Lee KW, Na KR, Cha DR, Kang YS, Progressive REnal disease and Medical Informatics and gEnomics Research (PREMIER) members. The hemeoxygenase-1 genotype is a risk factor to renal impairment of IgA nephropathy at diagnosis, which is a strong predictor of mortality. J Korean Med Sci 2009; 24 Suppl 1: S30-7.
-
(2009)
J Korean Med Sci
, vol.24
, Issue.SUPPL 1
-
-
Chin, H.J.1
Cho, H.J.2
Lee, T.W.3
Na, K.Y.4
Yoon, H.J.5
Chae, D.W.6
Kim, S.7
Jeon, U.S.8
Do, J.Y.9
Park, J.W.10
Yoon, K.W.11
Shin, Y.T.12
Lee, K.W.13
Na, K.R.14
Cha, D.R.15
Kang, Y.S.16
-
16
-
-
62449129906
-
Progressive REnal disease and Medical Informatics and gEnomics Research (PREMIER) members. Association of angiotensin II type 2 receptor gene A1818T polymorphism with progression of immunoglobulin A nephropathy in Korean patients
-
Yoon HJ, Chin HJ, Na KY, Chae DW, Kim S, Jeon US, Chung WK, Lee HH, Yang J, Kim S, Kwon YJ, Kim HC, Park SB, Kim HY, Lee TW, Progressive REnal disease and Medical Informatics and gEnomics Research (PREMIER) members. Association of angiotensin II type 2 receptor gene A1818T polymorphism with progression of immunoglobulin A nephropathy in Korean patients. J Korean Med Sci 2009; 24 Suppl 1: S38-43.
-
(2009)
J Korean Med Sci
, vol.24
, Issue.SUPPL 1
-
-
Yoon, H.J.1
Chin, H.J.2
Na, K.Y.3
Chae, D.W.4
Kim, S.5
Jeon, U.S.6
Chung, W.K.7
Lee, H.H.8
Yang, J.9
Kim, S.10
Kwon, Y.J.11
Kim, H.C.12
Park, S.B.13
Kim, H.Y.14
Lee, T.W.15
-
17
-
-
0001106451
-
A simplified equation to predict glomerular filtration rate from serum creatinine
-
Levey AS, Greene T, Kusek J, Beck GJ, Group MS. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol 2000; 11: A0828.
-
(2000)
J Am Soc Nephrol
, vol.11
-
-
Levey, A.S.1
Greene, T.2
Kusek, J.3
Beck, G.J.4
Group, M.S.5
-
18
-
-
78650768052
-
-
Ministry for Health, Welfare, and Family Affairs. Cancer incidence in 2006-2007, survival rate among patients with cancer developed in 1993-2007, and the prevalence of cancer in 2007 in the Korean population. Available at, [accessed on 1 Sep]
-
Ministry for Health, Welfare, and Family Affairs. Cancer incidence in 2006-2007, survival rate among patients with cancer developed in 1993-2007, and the prevalence of cancer in 2007 in the Korean population. Available at http://www.cancer.go.kr/cms/data/edudata/1363101_1619.html [accessed on 1 Sep 2010].
-
(2010)
-
-
-
19
-
-
0020032239
-
The nephrotic syndrome in adults aged over 60: etiology, evolution and treatment of 76 cases
-
Zech P, Colon S, Pointet P, Deteix P, Labeeuw M, Leitienne P. The nephrotic syndrome in adults aged over 60: etiology, evolution and treatment of 76 cases. Clin Nephrol 1982; 17: 232-6.
-
(1982)
Clin Nephrol
, vol.17
, pp. 232-236
-
-
Zech, P.1
Colon, S.2
Pointet, P.3
Deteix, P.4
Labeeuw, M.5
Leitienne, P.6
-
21
-
-
51749120817
-
VATTC Trial. Association of ACE inhibitors and angiotensin receptor blockers with keratinocyte cancer prevention in the randomized VATTC trial
-
Christian JB, Lapane KL, Hume AL, Eaton CB, Weinstock MA. VATTC Trial. Association of ACE inhibitors and angiotensin receptor blockers with keratinocyte cancer prevention in the randomized VATTC trial. J Natl Cancer Inst 2008; 100: 1223-32.
-
(2008)
J Natl Cancer Inst
, vol.100
, pp. 1223-1232
-
-
Christian, J.B.1
Lapane, K.L.2
Hume, A.L.3
Eaton, C.B.4
Weinstock, M.A.5
-
22
-
-
13844280904
-
Polymorphisms in angiotensin II type 1 receptor and angiotensin I-converting enzyme genes and breast cancer risk among Chinese women in Singapore
-
Koh WP, Yuan JM, Van Den Berg D, Lee HP, Yu MC. Polymorphisms in angiotensin II type 1 receptor and angiotensin I-converting enzyme genes and breast cancer risk among Chinese women in Singapore. Carcinogenesis 2005; 26: 459-64.
-
(2005)
Carcinogenesis
, vol.26
, pp. 459-464
-
-
Koh, W.P.1
Yuan, J.M.2
Van Den Berg, D.3
Lee, H.P.4
Yu, M.C.5
-
23
-
-
0034805542
-
Growth stimulatory angiotensin II type-1 receptor is upregulated in breast hyperplasia and in situ carcinoma but not in invasive carcinoma
-
De Paepe B, Verstraeten VL, De Potter CR, Vakaet LA, Bullock GR. Growth stimulatory angiotensin II type-1 receptor is upregulated in breast hyperplasia and in situ carcinoma but not in invasive carcinoma. Histochem Cell Biol 2001; 116: 247-54.
-
(2001)
Histochem Cell Biol
, vol.116
, pp. 247-254
-
-
De Paepe, B.1
Verstraeten, V.L.2
De Potter, C.R.3
Vakaet, L.A.4
Bullock, G.R.5
-
24
-
-
67650165085
-
Analytical review of the evidence for renoprotection by renin-angiotensin-aldosterone system blockade in chronic kidney disease-a call for caution
-
Onuigbo MA. Analytical review of the evidence for renoprotection by renin-angiotensin-aldosterone system blockade in chronic kidney disease-a call for caution. Nephron Clin Pract 2009; 113: c63-9.
-
(2009)
Nephron Clin Pract
, vol.113
-
-
Onuigbo, M.A.1
-
25
-
-
29244485406
-
Pilot study of angiotensin II receptor blocker in advanced hormone-refractory prostate cancer
-
Uemura H, Hasumi H, Kawahara T, Sugiura S, Miyoshi Y, Nakaigawa N, Teranishi J, Noguchi K, Ishiguro H, Kubota Y. Pilot study of angiotensin II receptor blocker in advanced hormone-refractory prostate cancer. Int J Clin Oncol 2005; 10: 405-10.
-
(2005)
Int J Clin Oncol
, vol.10
, pp. 405-410
-
-
Uemura, H.1
Hasumi, H.2
Kawahara, T.3
Sugiura, S.4
Miyoshi, Y.5
Nakaigawa, N.6
Teranishi, J.7
Noguchi, K.8
Ishiguro, H.9
Kubota, Y.10
-
26
-
-
48749090567
-
Telmisartan is a potent target for prevention and treatment in human prostate cancer
-
Funao K, Matsuyama M, Kawahito Y, Sano H, Chargui J, Touraine JL, Nakatani T, Yoshimura R. Telmisartan is a potent target for prevention and treatment in human prostate cancer. Oncol Rep 2008; 20: 295-300.
-
(2008)
Oncol Rep
, vol.20
, pp. 295-300
-
-
Funao, K.1
Matsuyama, M.2
Kawahito, Y.3
Sano, H.4
Chargui, J.5
Touraine, J.L.6
Nakatani, T.7
Yoshimura, R.8
-
27
-
-
69049113864
-
Impact of angiotensin I converting enzyme inhibitors and angiotensin II type 1 receptor blockers on survival in patients with advanced non-small-cell lung cancer undergoing first-line platinum-based chemotherapy
-
Wilop S, von Hobe S, Crysandt M, Esser A, Osieka R, Jost E. Impact of angiotensin I converting enzyme inhibitors and angiotensin II type 1 receptor blockers on survival in patients with advanced non-small-cell lung cancer undergoing first-line platinum-based chemotherapy. J Cancer Res Clin Oncol 2009; 135: 1429-35.
-
(2009)
J Cancer Res Clin Oncol
, vol.135
, pp. 1429-1435
-
-
Wilop, S.1
von Hobe, S.2
Crysandt, M.3
Esser, A.4
Osieka, R.5
Jost, E.6
-
28
-
-
13844255555
-
Angiotensin type 1a receptor signaling-dependent induction of vascular endothelial growth factor in stroma is relevant to tumor-associated angiogenesis and tumor growth
-
Fujita M, Hayashi I, Yamashina S, Fukamizu A, Itoman M, Majima M. Angiotensin type 1a receptor signaling-dependent induction of vascular endothelial growth factor in stroma is relevant to tumor-associated angiogenesis and tumor growth. Carcinogenesis 2005; 26: 271-9.
-
(2005)
Carcinogenesis
, vol.26
, pp. 271-279
-
-
Fujita, M.1
Hayashi, I.2
Yamashina, S.3
Fukamizu, A.4
Itoman, M.5
Majima, M.6
-
29
-
-
0035527477
-
Measurement of the systemic inflammatory response predicts cancerspecific and non-cancer survival in patients with cancer
-
McMillan DC, Elahi MM, Sattar N, Angerson WJ, Johnstone J, McArdle CS. Measurement of the systemic inflammatory response predicts cancerspecific and non-cancer survival in patients with cancer. Nutr Cancer 2001; 41: 64-9.
-
(2001)
Nutr Cancer
, vol.41
, pp. 64-69
-
-
McMillan, D.C.1
Elahi, M.M.2
Sattar, N.3
Angerson, W.J.4
Johnstone, J.5
McArdle, C.S.6
-
30
-
-
3242678224
-
Angiotensin II receptor blocker shows antiproliferative activity in prostate cancer cells: a possibility of tyrosine kinase inhibitor of growth factor
-
Uemura H, Ishiguro H, Nakaigawa N, Nagashima Y, Miyoshi Y, Fujinami K, Sakaguchi A, Kubota Y. Angiotensin II receptor blocker shows antiproliferative activity in prostate cancer cells: a possibility of tyrosine kinase inhibitor of growth factor. Mol Cancer Ther 2003; 2: 1139-47.
-
(2003)
Mol Cancer Ther
, vol.2
, pp. 1139-1147
-
-
Uemura, H.1
Ishiguro, H.2
Nakaigawa, N.3
Nagashima, Y.4
Miyoshi, Y.5
Fujinami, K.6
Sakaguchi, A.7
Kubota, Y.8
|